cGMP blues and Durbin on the warpath (again)
The month got off to a fractious start with Senators Dick Durbin and Richard Blumenthal asking tough questions about cGMP compliance in the supplement trade after an article in The Chicago Tribune claimed serious and widespread problems. Click here
However, a learning curve for GMP compliance is to be expected, American Herbal Products Association president Michael McGuffin told Durbin’s staff in a meeting on July 13. Click here for details.
Jarrow Formulas also issued a detailed rebuttal of the claims in the article. Click here.
Meanwhile, the FDA made it clear that it will go beyond just sending warning letters for GMP violations after filing an injunction against a NY supplement manufacturer. click here.
